Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01920906 · ClinicalTrials.gov registry record · NA

Comparative Analysis of Small and Large Plaque Psoriasis

A NA study, sponsored by Rockefeller University.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT01920906 is a NA study that has completed, run by Rockefeller University. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01920906, a NA study, has completed, sponsored by Rockefeller University.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

Psoriasis is a chronic, debilitating skin disorder with an estimated prevalence of 2%. Psoriatic skin lesions start with initial pinhead-sized macules and then coalesce into plaques of varying sizes. Despite the great strides in the studies for psoriasis, it is still unclear why psoriatic skin lesions start with small macules and then spread peripherally. To study peripheral spreading of psoriasis, investigators plan to study small plaque psoriasis in comparison to large plaque psoriasis in the Korean population. Large plaque psoriasis is the most common form of psoriasis, seen in approximately 90% of all psoriasis participants. Large psoriatic plaques are \>5 cm in size and localize to the extensor aspects of the elbows, knees, scalp, and genital area. On the other hand, small plaque psoriasis is the common or typical form of psoriasis that occurs particularly in Korea and other Asian countries. Korean small plaque psoriasis, even when chronic, remains \<2 cm in size and is widely distributed on the upper trunk and proximal extremities. Investigators hypothesize that the expression of immune-related genes are different between small and large plaque psoriasis. The study of a genetically homogeneous cohort, characterized by the relatively high prevalence of small plaque psoriasis in the Korean population, may filter out spurious signals while allowing for significant associations to emerge from a relatively low number of participants. By comparing small and large plaque psoriasis, it is expected this study could lead to new understandings of the mechanisms involved in spreading of psoriatic plaques and provide new insights into psoriasis development.

Interventions

  • PROCEDURE Skin biopsy and blood test

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2014-01
Est. Completion 2015-06
Phase NA

Sponsor

Rockefeller University

117 total trials

What the Registry Record Tells You About NCT01920906

The ClinicalTrials.gov registry entry for NCT01920906 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Skin biopsy and blood test is the first listed.

NCT01920906 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01920906 about?

NCT01920906 is a clinical study titled "Comparative Analysis of Small and Large Plaque Psoriasis". Psoriasis is a chronic, debilitating skin disorder with an estimated prevalence of 2%. Psoriatic skin lesions start with initial pinhead-sized macules and then coalesce into plaques of varying sizes. Despite the great strides in the studies for psoriasis, it is still unclear why psoriatic skin lesio...

What is the current status of trial NCT01920906?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2014-01. Estimated completion is 2015-06.

What interventions are being tested in trial NCT01920906?

The interventions under investigation include: Skin biopsy and blood test (PROCEDURE).

Who is sponsoring clinical trial NCT01920906?

This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.